MLAB

+ Watchlist + Portfolio

Mesa Laboratories, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $119.72
52-Week Range: $58.83 – $121.90
Market Cap: $666.75M
P/E (TTM): 140.18
EPS (TTM): 0.85
Dividend Yield: 0.53%

Advanced Metrics

Price/Book: 3.53
PEG Ratio: —
Return on Equity: 2.66%
Return on Assets: 3.29%
Gross Margin: 64.21%
Operating Margin: 11.69%
Profit Margin: 1.92%
Current Ratio: 1.79
Debt/Equity: 0.85
Total Debt: $161.35M
Free Cash Flow: $53.38M
Revenue Growth: 1.00%
Earnings Growth: -42.40%
Enterprise Value: $799.05M

MLAB Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Revenue	$219.08M	$216.19M	$240.98M	$249.13M
Cost of Revenue	$85.39M	$82.94M	$90.11M	$90.86M
Gross Profit	$133.69M	$133.25M	$150.87M	$158.27M
Research & Development	$20.49M	$19.30M	$19.52M	$20.31M
Selling, General & Admin	$109.88M	$111.49M	$115.02M	$119.45M
Operating Expenses	$130.37M	$130.79M	$134.53M	$139.76M
Operating Income	$3.32M	$2.46M	$16.34M	$18.51M
EBITDA	$37.52M	-$238.38M	$42.35M	$45.98M
Pretax Income	-$389.00K	-$275.65M	$5.96M	$12.01M
Income Tax	-$1.32M	-$21.40M	$7.93M	$5.30M
Net Income	$930.00K	-$254.25M	-$1.97M	$6.71M
Diluted EPS	0.17	-47.20	-0.36	—
Diluted Shares	5.36M	5.39M	5.42M	—

MLAB Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$32.91M	$28.21M	$27.32M	$26.93M
Receivables	$42.55M	$39.05M	$41.97M	$44.10M
Inventory	$34.64M	$32.67M	$25.36M	$26.37M
Current Assets	$118.97M	$109.35M	$102.69M	$106.27M
Total Assets	$661.83M	$446.80M	$433.35M	$427.75M
Current Liabilities	$43.36M	$44.31M	$163.96M	$61.90M
Long-Term Debt	$183.27M	$221.70M	$76.90M	$145.86M
Total Debt	$186.14M	$224.68M	$181.47M	$155.17M
Total Liabilities	$268.35M	$301.40M	$273.52M	$241.50M
Retained Earnings	$74.20M	-$183.49M	-$188.94M	-$185.75M
Shareholders' Equity	$393.48M	$145.39M	$159.83M	$186.25M
Working Capital	$75.62M	$65.04M	-$61.28M	$44.37M
Net Debt	$150.36M	$193.48M	$150.63M	$124.55M

MLAB Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	$27.98M	$44.13M	$46.81M	$42.83M
Capital Expenditure	-$4.54M	-$2.57M	-$4.50M	-$3.25M
Free Cash Flow	$23.44M	$41.57M	$42.31M	$39.58M
Depreciation & Amortisation	$33.13M	$31.57M	$24.53M	$23.27M
Stock-Based Compensation	$12.54M	$11.94M	$13.14M	$17.87M
Investing Cash Flow	-$9.49M	-$81.31M	-$4.50M	-$3.25M
Financing Cash Flow	-$33.33M	$32.84M	-$44.51M	-$41.85M
Dividends Paid	-$3.41M	-$3.45M	-$3.47M	-$3.52M
Net Change in Cash	-$14.84M	-$4.34M	-$2.20M	-$2.27M

MLAB Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$62.13M	$59.54M	$60.74M	$65.13M	$63.72M
Cost of Revenue	$23.72M	$22.60M	$23.41M	$23.33M	$21.52M
Gross Profit	$38.41M	$36.94M	$37.33M	$41.80M	$42.20M
Research & Development	$5.10M	$4.98M	$5.05M	$5.03M	$5.25M
Selling, General & Admin	$31.85M	$28.89M	$27.56M	$28.79M	$34.21M
Operating Expenses	$36.94M	$33.88M	$32.61M	$33.82M	$39.46M
Operating Income	$1.47M	$3.06M	$4.72M	$7.97M	$2.75M
EBITDA	$10.48M	$15.17M	$10.71M	$13.35M	$6.75M
Pretax Income	$461.00K	$7.01M	$2.00M	$4.60M	-$1.59M
Income Tax	$7.58M	$2.27M	-$477.00K	$966.00K	$2.54M
Net Income	-$7.11M	$4.74M	$2.48M	$3.63M	-$4.14M
Diluted EPS	-1.31	0.85	0.45	0.65	-0.75
Diluted Shares	5.44M	5.55M	5.54M	5.57M	5.54M

MLAB Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$27.32M	$21.28M	$20.42M	$28.98M	$26.93M
Receivables	$41.97M	$39.07M	$40.09M	$40.23M	$44.10M
Inventory	$25.36M	$28.11M	$27.74M	$26.56M	$26.37M
Current Assets	$102.69M	$98.26M	$97.43M	$105.63M	$106.27M
Total Assets	$433.35M	$435.74M	$430.35M	$434.85M	$427.75M
Current Liabilities	$163.96M	$149.49M	$48.30M	$54.40M	$61.90M
Long-Term Debt	$76.90M	$79.53M	$170.16M	$160.97M	$145.86M
Total Debt	$181.47M	$197.59M	$190.43M	$180.98M	$155.17M
Total Liabilities	$273.52M	$263.25M	$251.88M	$248.16M	$241.50M
Retained Earnings	-$188.94M	-$185.07M	-$183.47M	-$180.73M	-$185.75M
Shareholders' Equity	$159.83M	$172.50M	$178.47M	$186.69M	$186.25M
Working Capital	-$61.28M	-$51.24M	$49.14M	$51.24M	$44.37M
Net Debt	$150.63M	$159.91M	$154.43M	$137.15M	$124.55M

MLAB Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$12.66M	$1.89M	$8.22M	$18.75M	$13.96M
Capital Expenditure	-$1.01M	-$1.01M	-$1.09M	-$732.00K	-$417.00K
Free Cash Flow	$11.66M	$884.00K	$7.13M	$18.02M	$13.54M
Depreciation & Amortisation	$7.50M	$5.96M	$5.85M	$5.71M	$5.75M
Stock-Based Compensation	$3.14M	$3.88M	$3.81M	$3.38M	$6.79M
Investing Cash Flow	-$1.01M	-$1.01M	-$1.09M	-$732.00K	-$417.00K
Financing Cash Flow	-$16.19M	-$8.43M	-$7.88M	-$9.79M	-$15.76M
Dividends Paid	-$870.00K	-$873.00K	-$882.00K	-$884.00K	-$884.00K
Net Change in Cash	-$4.54M	-$7.54M	-$753.00K	$8.24M	-$2.21M

Market Snapshot

About

Mesa Laboratories manufactures and distributes quality control instruments and disposable products for the pharmaceutical, healthcare, industrial, and environmental markets. The company provides calibration systems, biological indicators, sterilization monitoring, and continuous monitoring systems for critical environments.